NFkappaB and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with TNFalpha.

Standard

NFkappaB and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with TNFalpha. / Tapalaga, Dan; Tiegs, Gisa; Angermüller, Sabine.

In: J HISTOCHEM CYTOCHEM, Vol. 50, No. 12, 12, 2002, p. 1599-1609.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{c45343c0de6244ffa3414a0b1a8ef877,
title = "NFkappaB and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with TNFalpha.",
abstract = "Tumor necrosis factor-alpha (TNFalpha) induces apoptosis in hepatocytes only under transcriptional arrest induced by galactosamine (GalN). In this study we demonstrated the shuttle of the transcription factor NFkappaB (nuclear factor-kappa B) in the liver tissue of mice within 30 min-4.5 hr hours after GalN/TNFalpha treatment. NFkappaB translocation from cytoplasm to the nucleus is initiated by its separation from the inhibitory IkappaB proteins which include IkappaBalpha, IkappaBbeta, and IkappaB. Thirty minutes after GalN/TNFalpha administration, NFkappaBp65 in hepatocellular nuclei becomes increasingly detectable and reaches its highest level after 2.5 hr. Then export back into cytoplasm begins but, surprisingly, approximately 30% of NFkappaB remains in the nuclear fraction and appears as an immunoprecipitate in the nuclei of apoptotic hepatocytes. Non-apoptotic hepatocytes do not show any reaction product in the nuclei 4.5 hr after treatment. Correspondingly, the amount of dissociated IkappaBbeta decreases in the cytoplasm up to 2.5 hr and increases again afterwards, although it does not reach the level of the control samples. No evidence of IkappaBbeta in the nuclei was found either immunocytochemically or biochemically. Caspase-3 activity, which is responsible for apoptosis, increases significantly after 3.5 hr. At that time, apoptotic hepatocytes can occasionally be observed and, 4.5 hr after GalN/TNFalpha treatment, constitute approximately 30% of the hepatocytes.",
keywords = "Animals, Male, Immunohistochemistry, Mice, Mice, Inbred BALB C, Blotting, Western, In Situ Nick-End Labeling, *Apoptosis, Cell Nucleus/metabolism, NF-kappa B/*metabolism, Caspase 3, Caspases/*metabolism, Galactosamine/*pharmacology, Hepatocytes/cytology/*metabolism/ultrastructure, Plastic Embedding, Tumor Necrosis Factor-alpha/*pharmacology/physiology, Animals, Male, Immunohistochemistry, Mice, Mice, Inbred BALB C, Blotting, Western, In Situ Nick-End Labeling, *Apoptosis, Cell Nucleus/metabolism, NF-kappa B/*metabolism, Caspase 3, Caspases/*metabolism, Galactosamine/*pharmacology, Hepatocytes/cytology/*metabolism/ultrastructure, Plastic Embedding, Tumor Necrosis Factor-alpha/*pharmacology/physiology",
author = "Dan Tapalaga and Gisa Tiegs and Sabine Angerm{\"u}ller",
year = "2002",
language = "English",
volume = "50",
pages = "1599--1609",
journal = "J HISTOCHEM CYTOCHEM",
issn = "0022-1554",
publisher = "Histochemical Society Inc.",
number = "12",

}

RIS

TY - JOUR

T1 - NFkappaB and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with TNFalpha.

AU - Tapalaga, Dan

AU - Tiegs, Gisa

AU - Angermüller, Sabine

PY - 2002

Y1 - 2002

N2 - Tumor necrosis factor-alpha (TNFalpha) induces apoptosis in hepatocytes only under transcriptional arrest induced by galactosamine (GalN). In this study we demonstrated the shuttle of the transcription factor NFkappaB (nuclear factor-kappa B) in the liver tissue of mice within 30 min-4.5 hr hours after GalN/TNFalpha treatment. NFkappaB translocation from cytoplasm to the nucleus is initiated by its separation from the inhibitory IkappaB proteins which include IkappaBalpha, IkappaBbeta, and IkappaB. Thirty minutes after GalN/TNFalpha administration, NFkappaBp65 in hepatocellular nuclei becomes increasingly detectable and reaches its highest level after 2.5 hr. Then export back into cytoplasm begins but, surprisingly, approximately 30% of NFkappaB remains in the nuclear fraction and appears as an immunoprecipitate in the nuclei of apoptotic hepatocytes. Non-apoptotic hepatocytes do not show any reaction product in the nuclei 4.5 hr after treatment. Correspondingly, the amount of dissociated IkappaBbeta decreases in the cytoplasm up to 2.5 hr and increases again afterwards, although it does not reach the level of the control samples. No evidence of IkappaBbeta in the nuclei was found either immunocytochemically or biochemically. Caspase-3 activity, which is responsible for apoptosis, increases significantly after 3.5 hr. At that time, apoptotic hepatocytes can occasionally be observed and, 4.5 hr after GalN/TNFalpha treatment, constitute approximately 30% of the hepatocytes.

AB - Tumor necrosis factor-alpha (TNFalpha) induces apoptosis in hepatocytes only under transcriptional arrest induced by galactosamine (GalN). In this study we demonstrated the shuttle of the transcription factor NFkappaB (nuclear factor-kappa B) in the liver tissue of mice within 30 min-4.5 hr hours after GalN/TNFalpha treatment. NFkappaB translocation from cytoplasm to the nucleus is initiated by its separation from the inhibitory IkappaB proteins which include IkappaBalpha, IkappaBbeta, and IkappaB. Thirty minutes after GalN/TNFalpha administration, NFkappaBp65 in hepatocellular nuclei becomes increasingly detectable and reaches its highest level after 2.5 hr. Then export back into cytoplasm begins but, surprisingly, approximately 30% of NFkappaB remains in the nuclear fraction and appears as an immunoprecipitate in the nuclei of apoptotic hepatocytes. Non-apoptotic hepatocytes do not show any reaction product in the nuclei 4.5 hr after treatment. Correspondingly, the amount of dissociated IkappaBbeta decreases in the cytoplasm up to 2.5 hr and increases again afterwards, although it does not reach the level of the control samples. No evidence of IkappaBbeta in the nuclei was found either immunocytochemically or biochemically. Caspase-3 activity, which is responsible for apoptosis, increases significantly after 3.5 hr. At that time, apoptotic hepatocytes can occasionally be observed and, 4.5 hr after GalN/TNFalpha treatment, constitute approximately 30% of the hepatocytes.

KW - Animals

KW - Male

KW - Immunohistochemistry

KW - Mice

KW - Mice, Inbred BALB C

KW - Blotting, Western

KW - In Situ Nick-End Labeling

KW - Apoptosis

KW - Cell Nucleus/metabolism

KW - NF-kappa B/metabolism

KW - Caspase 3

KW - Caspases/metabolism

KW - Galactosamine/pharmacology

KW - Hepatocytes/cytology/metabolism/ultrastructure

KW - Plastic Embedding

KW - Tumor Necrosis Factor-alpha/pharmacology/physiology

KW - Animals

KW - Male

KW - Immunohistochemistry

KW - Mice

KW - Mice, Inbred BALB C

KW - Blotting, Western

KW - In Situ Nick-End Labeling

KW - Apoptosis

KW - Cell Nucleus/metabolism

KW - NF-kappa B/metabolism

KW - Caspase 3

KW - Caspases/metabolism

KW - Galactosamine/pharmacology

KW - Hepatocytes/cytology/metabolism/ultrastructure

KW - Plastic Embedding

KW - Tumor Necrosis Factor-alpha/pharmacology/physiology

M3 - SCORING: Journal article

VL - 50

SP - 1599

EP - 1609

JO - J HISTOCHEM CYTOCHEM

JF - J HISTOCHEM CYTOCHEM

SN - 0022-1554

IS - 12

M1 - 12

ER -